Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
PaperCitations, authors & open-access status
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,612 citations, 2014 year and bronze oa status.
1,612
Citations
2014
Year
bronze
OA Status